ALL 0 3 0 3 B-cancer
with 4 8 4 8 O
any 9 12 9 12 O
morphological 13 26 13 26 O
evidence 27 35 27 35 O
of 36 38 36 38 O
disease 39 46 39 46 O
will 47 51 47 51 O
not 52 55 52 55 O
be 56 58 56 58 O
eligible 59 67 59 67 O

Active 0 6 68 74 O
involvement 7 18 75 86 O
of 19 21 87 89 O
the 22 25 90 93 O
central 26 33 94 101 O
nervous 34 41 102 109 O
system 42 48 110 116 O
with 49 53 117 121 O
malignancy 54 64 122 132 B-cancer

Acute 0 5 133 138 B-cancer
lymphoid 6 14 139 147 I-cancer
leukemia 15 23 148 156 I-cancer
in 24 26 157 159 O
1st 27 30 160 163 B-treatment
or 31 33 164 166 I-treatment
2nd 34 37 167 170 I-treatment
morphological 38 51 171 184 I-treatment
remission 52 61 185 194 I-treatment

Acute 0 5 195 200 B-cancer
myeloid 6 13 201 208 I-cancer
leukemia 14 22 209 217 I-cancer
with 23 27 218 222 O
high 28 32 223 227 O
risk 33 37 228 232 O
features 38 46 233 241 O

Adequate 0 8 242 250 O
liver 9 14 251 256 O
function 15 23 257 265 O
as 24 26 266 268 O
defined 27 34 269 276 O
by 35 37 277 279 O
a 38 39 280 281 O
serum 40 45 282 287 B-clinical_variable
bilirubin 46 55 288 297 I-clinical_variable
< 56 57 298 299 O
1.8 57 60 299 302 B-upper_bound
, 60 61 302 303 O
aspartate 62 71 304 313 B-clinical_variable
aminotransferase 72 88 314 330 I-clinical_variable
( 89 90 331 332 I-clinical_variable
AST 90 93 332 335 I-clinical_variable
) 93 94 335 336 I-clinical_variable
or 95 97 337 339 O
alanine 98 105 340 347 B-clinical_variable
aminotransferase 106 122 348 364 I-clinical_variable
( 123 124 365 366 I-clinical_variable
ALT 124 127 366 369 I-clinical_variable
) 127 128 369 370 I-clinical_variable
< 129 130 371 372 O
2.5X 131 135 373 377 B-upper_bound
upper 136 141 378 383 I-upper_bound
limit 142 147 384 389 I-upper_bound
of 148 150 390 392 I-upper_bound
normal 151 157 393 399 I-upper_bound

Age 0 3 400 403 B-age
greater 4 11 404 411 O
than 12 16 412 416 O
or 17 19 417 419 O
equal 20 25 420 425 O
to 26 28 426 428 O
60 29 31 429 431 B-lower_bound

Any 0 3 432 435 O
hematological 4 17 436 449 B-cancer
malignancy 18 28 450 460 I-cancer
not 29 32 461 464 O
cited 33 38 465 470 O
above 39 44 471 476 O
which 45 50 477 482 O
is 51 53 483 485 O
thought 54 61 486 493 O
to 62 64 494 496 O
be 65 67 497 499 O
high 68 72 500 504 O
- 72 73 504 505 O
risk 73 77 505 509 O
with 78 82 510 514 O
increased 83 92 515 524 O
chance 93 99 525 531 O
of 100 102 532 534 O
post 103 107 535 539 O
HSCT 108 112 540 544 B-treatment
relapse 113 120 545 552 I-treatment

Any 0 3 553 556 O
hematological 4 17 557 570 O
malignancy 18 28 571 581 B-cancer
or 29 31 582 584 O
dyscrasia 32 41 585 594 B-chronic_disease
not 42 45 595 598 O
cited 46 51 599 604 O
above 52 57 605 610 O
which 58 63 611 616 O
is 64 66 617 619 O
thought 67 74 620 627 O
to 75 77 628 630 O
be 78 80 631 633 O
high 81 85 634 638 O
- 85 86 638 639 O
risk 86 90 639 643 O
with 91 95 644 648 O
increased 96 105 649 658 O
chance 106 112 659 665 O
of 113 115 666 668 O
post 116 120 669 673 O
HSCT 121 125 674 678 B-treatment
relapse 126 133 679 686 O

Any 0 3 687 690 O
patient 4 11 691 698 O
who 12 15 699 702 O
has 16 19 703 706 O
an 20 22 707 709 O
aggressive 23 33 710 720 O
disease 34 41 721 728 O
that 42 46 729 733 O
would 47 52 734 739 O
normally 53 61 740 748 O
be 62 64 749 751 O
treated 65 72 752 759 O
on 73 75 760 762 O
a 76 77 763 764 O
myeloablative 78 91 765 778 B-treatment
study 92 97 779 784 O
, 97 98 784 785 O
but 99 102 786 789 O
is 103 105 790 792 O
prevented 106 115 793 802 O
from 116 120 803 807 O
doing 121 126 808 813 O
so 127 129 814 816 O
by 130 132 817 819 O
factors 133 140 820 827 O
in 141 143 828 830 O
their 144 149 831 836 O
past 150 154 837 841 O
medical 155 162 842 849 O
history 163 170 850 857 O

Any 0 3 858 861 O
patient 4 11 862 869 O
with 12 16 870 874 O
a 17 18 875 876 O
high 19 23 877 881 O
- 23 24 881 882 O
risk 24 28 882 886 O
hematologic 29 40 887 898 O
or 41 43 899 901 O
oncologic 44 53 902 911 O
diagnosis 54 63 912 921 O
in 64 66 922 924 O
which 67 72 925 930 O
allogeneic 73 83 931 941 B-treatment
HSCT 84 88 942 946 I-treatment
is 89 91 947 949 O
thought 92 99 950 957 O
to 100 102 958 960 O
be 103 105 961 963 O
beneficial 106 116 964 974 O
, 116 117 974 975 O
and 118 121 976 979 O
in 122 124 980 982 O
whom 125 129 983 987 O
front 130 135 988 993 B-treatment
- 135 136 993 994 I-treatment
line 136 140 994 998 I-treatment
therapy 141 148 999 1006 I-treatment
has 149 152 1007 1010 O
already 153 160 1011 1018 O
been 161 165 1019 1023 O
applied 166 173 1024 1031 O

Any 0 3 1032 1035 O
relapse 4 11 1036 1043 O
or 12 14 1044 1046 O
primary 15 22 1047 1054 B-chronic_disease
refractory 23 33 1055 1065 I-chronic_disease
disease 34 41 1066 1073 I-chronic_disease

Chronic 0 7 1074 1081 B-cancer
myeloid 8 15 1082 1089 I-cancer
leukemia 16 24 1090 1098 I-cancer
( 25 26 1099 1100 I-cancer
CML 26 29 1100 1103 I-cancer
) 29 30 1103 1104 I-cancer
resistant 31 40 1105 1114 O
to 41 43 1115 1117 O
signal 44 50 1118 1124 B-treatment
transducer 51 61 1125 1135 I-treatment
inhibitor 62 71 1136 1145 I-treatment
( 72 73 1146 1147 I-treatment
STI 73 76 1147 1150 I-treatment
) 76 77 1150 1151 I-treatment
therapy 78 85 1152 1159 I-treatment

Creatinine 0 10 1160 1170 B-clinical_variable
Clearance 11 20 1171 1180 I-clinical_variable
of 21 23 1181 1183 O
≥ 24 25 1184 1185 O
60 26 28 1186 1188 B-lower_bound
mL 29 31 1189 1191 I-lower_bound
/ 31 32 1191 1192 I-lower_bound
min 32 35 1192 1195 I-lower_bound

Diffusion 0 9 1196 1205 B-clinical_variable
Lung 10 14 1206 1210 I-clinical_variable
Capacity 15 23 1211 1219 I-clinical_variable
of 24 26 1220 1222 I-clinical_variable
Oxygen 27 33 1223 1229 I-clinical_variable
( 34 35 1230 1231 I-clinical_variable
DLCO 35 39 1231 1235 I-clinical_variable
) 39 40 1235 1236 I-clinical_variable
> 41 42 1237 1238 O
50 42 44 1238 1240 B-lower_bound
% 44 45 1240 1241 I-lower_bound
of 46 48 1242 1244 O
predicted 49 58 1245 1254 O
corrected 59 68 1255 1264 O
for 69 72 1265 1268 O
hemoglobin 73 83 1269 1279 O

Essential 0 9 1280 1289 B-cancer
Thrombocytopenia 10 26 1290 1306 I-cancer
or 27 29 1307 1309 O
Polycythemia 30 42 1310 1322 B-cancer
Vera 43 47 1323 1327 I-cancer
with 48 52 1328 1332 O
current 53 60 1333 1340 O
or 61 63 1341 1343 O
past 64 68 1344 1348 O
evidence 69 77 1349 1357 O
of 78 80 1358 1360 O
evolution 81 90 1361 1370 O
to 91 93 1371 1373 O
acute 94 99 1374 1379 B-cancer
leukemia 100 108 1380 1388 I-cancer

Examples 0 8 1389 1397 O
are 9 12 1398 1401 O
patients 13 21 1402 1410 O
with 22 26 1411 1415 O
previous 27 35 1416 1424 B-treatment
treatment 36 45 1425 1434 I-treatment
with 46 50 1435 1439 I-treatment
radiation 51 60 1440 1449 I-treatment
therapy 61 68 1450 1457 I-treatment
precluding 69 79 1458 1468 O
TBI 80 83 1469 1472 B-chronic_disease
, 83 84 1472 1473 O
or 85 87 1474 1476 O
a 88 89 1477 1478 O
past 90 94 1479 1483 O
history 95 102 1484 1491 O
of 103 105 1492 1494 O
myeloablative 106 119 1495 1508 B-treatment
therapy 120 127 1509 1516 I-treatment
, 127 128 1516 1517 O
precluding 129 139 1518 1528 O
a 140 141 1529 1530 O
2nd 142 145 1531 1534 O
myeloablative 146 159 1535 1548 B-treatment
regimen 160 167 1549 1556 I-treatment

Greater 0 7 1557 1564 O
than 8 12 1565 1569 O
3 13 14 1570 1571 B-lower_bound
cytogenetic 15 26 1572 1583 B-chronic_disease
abnormalities 27 40 1584 1597 I-chronic_disease
or 41 43 1598 1600 O
any 44 47 1601 1604 O
one 48 51 1605 1608 O
of 52 54 1609 1611 O
the 55 58 1612 1615 O
following 59 68 1616 1625 O
cytogenetic 69 80 1626 1637 O
abnormalities 81 94 1638 1651 O

HIV 0 3 1652 1655 B-chronic_disease
positive 4 12 1656 1664 O

Hodgkin 0 7 1665 1672 B-cancer
's 7 9 1672 1674 I-cancer
or 10 12 1675 1677 O
Non 13 16 1678 1681 B-cancer
- 16 17 1681 1682 I-cancer
Hodgkin 17 24 1682 1689 I-cancer
's 24 26 1689 1691 I-cancer
lymphoma 27 35 1692 1700 I-cancer
in 36 38 1701 1703 O
2nd 39 42 1704 1707 B-lower_bound
or 43 45 1708 1710 O
greater 46 53 1711 1718 O
remission 54 63 1719 1728 B-treatment
or 64 66 1729 1731 O
with 67 71 1732 1736 O
persistent 72 82 1737 1747 O
disease 83 90 1748 1755 O

Left 0 4 1756 1760 B-clinical_variable
ventricular 5 16 1761 1772 I-clinical_variable
end 17 20 1773 1776 I-clinical_variable
diastolic 21 30 1777 1786 I-clinical_variable
function 31 39 1787 1795 I-clinical_variable
( 40 41 1796 1797 I-clinical_variable
LVEF 41 45 1797 1801 I-clinical_variable
) 45 46 1801 1802 I-clinical_variable
of 47 49 1803 1805 O
> 50 51 1806 1807 O
50 51 53 1807 1809 B-lower_bound
% 53 54 1809 1810 I-lower_bound

Myelodysplasia 0 14 1811 1825 B-cancer
( 15 16 1826 1827 I-cancer
MDS 16 19 1827 1830 I-cancer
) 19 20 1830 1831 I-cancer
other 21 26 1832 1837 O
than 27 31 1838 1842 O
refractory 32 42 1843 1853 B-chronic_disease
anemia 43 49 1854 1860 I-chronic_disease
( 50 51 1861 1862 I-chronic_disease
RA 51 53 1862 1864 I-chronic_disease
) 53 54 1864 1865 I-chronic_disease
, 54 55 1865 1866 O
refractory 56 66 1867 1877 O
anemia 67 73 1878 1884 O
with 74 78 1885 1889 O
rare 79 83 1890 1894 B-chronic_disease
sideroblasts 84 96 1895 1907 I-chronic_disease
( 97 98 1908 1909 I-chronic_disease
RARS 98 102 1909 1913 I-chronic_disease
) 102 103 1913 1914 I-chronic_disease
, 103 104 1914 1915 O
or 105 107 1916 1918 O
isolated 108 116 1919 1927 B-chronic_disease
5q- 117 120 1928 1931 I-chronic_disease
syndrome 121 129 1932 1940 I-chronic_disease
subtypes 130 138 1941 1949 O

Myelofibrosis 0 13 1950 1963 B-chronic_disease
and 14 17 1964 1967 O
CMML 18 22 1968 1972 B-cancer

Myeloma 0 7 1973 1980 B-cancer
with 8 12 1981 1985 O
evidence 13 21 1986 1994 O
of 22 24 1995 1997 O
persistent 25 35 1998 2008 O
disease 36 43 2009 2016 O
after 44 49 2017 2022 O
front 50 55 2023 2028 B-treatment
- 55 56 2028 2029 I-treatment
line 56 60 2029 2033 I-treatment
therapy 61 68 2034 2041 I-treatment

Normal 0 6 2042 2048 O
cytogenetics 7 19 2049 2061 O
but 20 23 2062 2065 O
FLT3 24 28 2066 2070 B-cancer
/ 28 29 2070 2071 I-cancer
ITD 29 32 2071 2074 I-cancer
positive 33 41 2075 2083 O

Patients 0 8 2084 2092 B-clinical_variable
< 9 10 2093 2094 O
age 11 14 2095 2098 B-age
60 15 17 2099 2101 B-upper_bound
years 18 23 2102 2107 I-upper_bound
must 24 28 2108 2112 O
have 29 33 2113 2117 O
a 34 35 2118 2119 O
KPS 36 39 2120 2123 B-clinical_variable
of 40 42 2124 2126 O
≥80 43 46 2127 2130 O
% 46 47 2130 2131 I-lower_bound
and 48 51 2132 2135 O
an 52 54 2136 2138 O
HCT 55 58 2139 2142 B-clinical_variable
- 58 59 2142 2143 I-clinical_variable
CI 59 61 2143 2145 I-clinical_variable
score 62 67 2146 2151 I-clinical_variable
of 68 70 2152 2154 O
5 71 72 2155 2156 B-upper_bound
or 73 75 2157 2159 O
less 76 80 2160 2164 O

Patients 0 8 2165 2173 O
aged 9 13 2174 2178 B-age
60 14 16 2179 2181 B-lower_bound
to 17 19 2182 2184 O
65 20 22 2185 2187 B-upper_bound
years 23 28 2188 2193 I-upper_bound
must 29 33 2194 2198 O
have 34 38 2199 2203 O
a 39 40 2204 2205 O
KPS 41 44 2206 2209 B-clinical_variable
of 45 47 2210 2212 O
≥80 48 51 2213 2216 O
% 51 52 2216 2217 I-lower_bound
and 53 56 2218 2221 O
an 57 59 2222 2224 O
HCT 60 63 2225 2228 B-clinical_variable
- 63 64 2228 2229 I-clinical_variable
CI 64 66 2229 2231 I-clinical_variable
score 67 72 2232 2237 I-clinical_variable
of 73 75 2238 2240 O
4 76 77 2241 2242 B-upper_bound
or 78 80 2243 2245 O
less 81 85 2246 2250 O

Patients 0 8 2251 2259 O
aged 9 13 2260 2264 B-age
70 14 16 2265 2267 B-lower_bound
years 17 22 2268 2273 I-lower_bound
or 23 25 2274 2276 O
more 26 30 2277 2281 O
must 31 35 2282 2286 O
have 36 40 2287 2291 O
a 41 42 2292 2293 O
KPS 43 46 2294 2297 B-clinical_variable
of 47 49 2298 2300 O
90 50 52 2301 2303 O
% 52 53 2303 2304 O
and 54 57 2305 2308 O
an 58 60 2309 2311 O
HCT 61 64 2312 2315 B-clinical_variable
- 64 65 2315 2316 I-clinical_variable
CI 65 67 2316 2318 I-clinical_variable
score 68 73 2319 2324 O
of 74 76 2325 2327 O
2 77 78 2328 2329 B-upper_bound
or 79 81 2330 2332 O
less 82 86 2333 2337 O
( 87 88 2338 2339 O
Patients 88 96 2339 2347 O
with 97 101 2348 2352 O
greater 102 109 2353 2360 O
than 110 114 2361 2365 O
the 115 118 2366 2369 O
allowable 119 128 2370 2379 O
HCT 129 132 2380 2383 O
- 132 133 2383 2384 O
CI 133 135 2384 2386 O
points 136 142 2387 2393 O
for 143 146 2394 2397 O
age 147 150 2398 2401 O
can 151 154 2402 2405 O
be 155 157 2406 2408 O
enrolled 158 166 2409 2417 O
for 167 170 2418 2421 O
trial 171 176 2422 2427 O
with 177 181 2428 2432 O
approval 182 190 2433 2441 O
of 191 193 2442 2444 O
the 194 197 2445 2448 O
PI 198 200 2449 2451 B-clinical_variable
and 201 204 2452 2455 O
at 205 207 2456 2458 O
least 208 213 2459 2464 O
1 214 215 2465 2466 B-lower_bound
Co 216 218 2467 2469 O
- 218 219 2469 2470 O
I 219 220 2470 2471 O
not 221 224 2472 2475 O
on 225 227 2476 2478 O
the 228 231 2479 2482 O
primary 232 239 2483 2490 O
care 240 244 2491 2495 O
team 245 249 2496 2500 O
of 250 252 2501 2503 O
the 253 256 2504 2507 O
patient 257 264 2508 2515 O
) 264 265 2515 2516 O

Patients 0 8 2517 2525 O
in 9 11 2526 2528 O
this 12 16 2529 2533 O
category 17 25 2534 2542 O
require 26 33 2543 2550 O
specific 34 42 2551 2559 O
approval 43 51 2560 2568 O
of 52 54 2569 2571 O
the 55 58 2572 2575 O
PI 59 61 2576 2578 B-clinical_variable
and 62 65 2579 2582 O
the 66 69 2583 2586 O
TJU 70 73 2587 2590 B-clinical_variable
BMT 74 77 2591 2594 I-clinical_variable
attending 78 87 2595 2604 O
physician 88 97 2605 2614 O
group 98 103 2615 2620 O
for 104 107 2621 2624 O
entrance 108 116 2625 2633 O

Patients 0 8 2634 2642 O
must 9 13 2643 2647 O
be 14 16 2648 2650 O
willing 17 24 2651 2658 B-contraception_consent
to 25 27 2659 2661 I-contraception_consent
use 28 31 2662 2665 I-contraception_consent
contraception 32 45 2666 2679 I-contraception_consent
if 46 48 2680 2682 O
they 49 53 2683 2687 O
have 54 58 2688 2692 O
childbearing 59 71 2693 2705 O
potential 72 81 2706 2715 O

Patients 0 8 2716 2724 O
must 9 13 2725 2729 O
have 14 18 2730 2734 O
a 19 20 2735 2736 O
related 21 28 2737 2744 O
donor 29 34 2745 2750 O
who 35 38 2751 2754 O
is 39 41 2755 2757 O
at 42 44 2758 2760 O
least 45 50 2761 2766 O
a 51 52 2767 2768 O
4 53 54 2769 2770 B-lower_bound
antigen 55 62 2771 2778 O
match 63 68 2779 2784 O
at 69 71 2785 2787 O
the 72 75 2788 2791 O
Human 76 81 2792 2797 B-clinical_variable
Leukocyte 82 91 2798 2807 I-clinical_variable
Antigen 92 99 2808 2815 I-clinical_variable
( 100 101 2816 2817 I-clinical_variable
HLA)-A 101 107 2817 2823 I-clinical_variable
; 107 108 2823 2824 O
B 109 110 2825 2826 O
; 110 111 2826 2827 O
C 112 113 2828 2829 O
; 113 114 2829 2830 O
DR 115 117 2831 2833 O
loci 118 122 2834 2838 O

Patients 0 8 2839 2847 O
must 9 13 2848 2852 O
have 14 18 2853 2857 O
adequate 19 27 2858 2866 O
KPS 28 31 2867 2870 B-clinical_variable
and 32 35 2871 2874 O
HCT 36 39 2875 2878 B-clinical_variable
- 39 40 2878 2879 I-clinical_variable
CI 40 42 2879 2881 I-clinical_variable
scores 43 49 2882 2888 I-clinical_variable

Patients 0 8 2889 2897 O
who 9 12 2898 2901 O
have 13 17 2902 2906 O
received 18 26 2907 2915 O
alemtuzumab 27 38 2916 2927 B-treatment
or 39 41 2928 2930 O
ATG 42 45 2931 2934 B-treatment
within 46 52 2935 2941 O
8 53 54 2942 2943 B-upper_bound
weeks 55 60 2944 2949 I-upper_bound
of 61 63 2950 2952 O
the 64 67 2953 2956 O
transplant 68 78 2957 2967 B-treatment
admission 79 88 2968 2977 I-treatment

Patients 0 8 2978 2986 O
with 9 13 2987 2991 O
aplastic 14 22 2992 3000 B-chronic_disease
anemia 23 29 3001 3007 I-chronic_disease
may 30 33 3008 3011 O
be 34 36 3012 3014 O
treated 37 44 3015 3022 O
on 45 47 3023 3025 O
this 48 52 3026 3030 O
protocol 53 61 3031 3039 O
, 61 62 3039 3040 O
with 63 67 3041 3045 O
outcomes 68 76 3046 3054 O
reported 77 85 3055 3063 O
descriptively 86 99 3064 3077 O

Patients 0 8 3078 3086 O
with 9 13 3087 3091 O
evidence 14 22 3092 3100 O
of 23 25 3101 3103 O
another 26 33 3104 3111 O
malignancy 34 44 3112 3122 B-cancer
, 44 45 3122 3123 O
exclusive 46 55 3124 3133 O
of 56 58 3134 3136 O
a 59 60 3137 3138 O
skin 61 65 3139 3143 B-cancer
cancer 66 72 3144 3150 I-cancer
that 73 77 3151 3155 O
requires 78 86 3156 3164 O
only 87 91 3165 3169 O
local 92 97 3170 3175 B-treatment
treatment 98 107 3176 3185 I-treatment
, 107 108 3185 3186 O
should 109 115 3187 3193 O
not 116 119 3194 3197 O
be 120 122 3198 3200 O
enrolled 123 131 3201 3209 O
on 132 134 3210 3212 O
this 135 139 3213 3217 O
protocol 140 148 3218 3226 O

Patients 0 8 3227 3235 O
with 9 13 3236 3240 O
life 14 18 3241 3245 B-clinical_variable
expectancy 19 29 3246 3256 I-clinical_variable
of 30 32 3257 3259 O
< 33 34 3260 3261 O
6 35 36 3262 3263 B-upper_bound
months 37 43 3264 3270 I-upper_bound
for 44 47 3271 3274 O
reasons 48 55 3275 3282 O
other 56 61 3283 3288 O
than 62 66 3289 3293 O
their 67 72 3294 3299 O
underlying 73 83 3300 3310 O
hematologic 84 95 3311 3322 B-chronic_disease
/ 95 96 3322 3323 I-chronic_disease
oncologic 96 105 3323 3332 I-chronic_disease
disorder 106 114 3333 3341 I-chronic_disease

Patients 0 8 3342 3350 O
with 9 13 3351 3355 O
only 14 18 3356 3360 O
a 19 20 3361 3362 O
1 21 22 3363 3364 B-lower_bound
out 23 26 3365 3368 O
of 27 29 3369 3371 O
8 30 31 3372 3373 B-upper_bound
mismatch 32 40 3374 3382 O
in 41 43 3383 3385 O
the 44 47 3386 3389 O
GVH 48 51 3390 3393 O
direction 52 61 3394 3403 O
will 62 66 3404 3408 O
be 67 69 3409 3411 O
classified 70 80 3412 3422 O
in 81 83 3423 3425 O
the 84 87 3426 3429 O
matched 88 95 3430 3437 O
related 96 103 3438 3445 O
category 104 112 3446 3454 O

Pregnancy 0 9 3455 3464 B-pregnancy

Secondary 0 9 3465 3474 B-cancer
AML 10 13 3475 3478 I-cancer
( 14 15 3479 3480 O
prior 15 20 3480 3485 B-treatment
therapy 21 28 3486 3493 I-treatment
or 29 31 3494 3496 O
hematologic 32 43 3497 3508 B-cancer
malignancy 44 54 3509 3519 I-cancer
) 54 55 3519 3520 O

